Coe Capital Management’s NeoGenomics NEO Stock Holding History

Coe Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-66,545	Closed	-$535K	–	243
2016 Q2	$535K	Sell	66,545 -10,600	-14%	-$85K	0.18%	150
2016 Q1	$520K	Sell	77,145 -78,873	-51%	-$519K	0.17%	145
2015 Q4	$1.23M	Buy	156,018 +31,646	+25%	+$232K	0.49%	67
2015 Q3	$713K	Buy	124,372 +44,172	+55%	+$273K	0.26%	108
2015 Q2	$434K	Sell	80,200 -3,277	-4%	-$16.9K	0.16%	171
2015 Q1	$390K	Buy	83,477 +19,628	+31%	+$85.3K	0.16%	164
2014 Q4	$266K	Sell	63,849 -116,826	-65%	-$537K	0.08%	212
2014 Q3	$941K	Sell	180,675 -15,636	-8%	-$80.3K	0.35%	105
2014 Q2	$652K	Buy	+196,311	New	+$652K	0.23%	130

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

CRC

Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Coe Capital Management's NEO Position: Q3 2016 in Review

Coe Capital Management sold out of NeoGenomics (NEO) in Q3 2016, closing a stake of 66,545 shares — an estimated $535K sold.

Coe Capital Management first reported a position in NEO in Q2 2014 and held it in 9 quarters. The position peaked at $1.23M in Q4 2015. 138 funds tracked by Wall St. Rank hold NEO as of Q3 2016.

Coe Capital Management reported no remaining NeoGenomics position as of Q3 2016 after selling out during the quarter.
Coe Capital Management sold 66,545 NeoGenomics shares in Q3 2016, an estimated $535K.
Coe Capital Management first reported a position in NeoGenomics in Q2 2014 and held it in 9 quarters.
Coe Capital Management's NeoGenomics position peaked at $1.23M in Q4 2015.
138 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2016.

Based on Coe Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.